Previous Close | 0.6570 |
Open | 0.6750 |
Bid | 0.6438 x 100 |
Ask | 0.7179 x 100 |
Day's Range | 0.6651 - 0.7100 |
52 Week Range | 0.6020 - 5.2400 |
Volume | |
Avg. Volume | 789,911 |
Market Cap | 4.655M |
Beta (5Y Monthly) | 2.24 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -6.3500 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.00 |
Collaboration with leading telemedicine provider to offer marketing and distribution of STENDRA for Lemonaid Health's ED patients(Please see important safety information below) NEW YORK, NY / ACCESSWIRE / April 23, 2024 / Petros Pharmaceuticals, Inc. ...
(Please see important safety information below) NEW YORK, NY / ACCESSWIRE / April 16, 2024 / Petros Pharmaceuticals, Inc. ("Petros," or the "Company") (NASDAQ:PTPI), a company focused on expanding consumer access to medication through over-the- counter ...
Nitrate patients subgroup demonstrated 100% correct self-selection when utilizing the web app technology with the drug facts label compared to 40% when using drug facts label alone (among 86% vs. 56% of all users) underscoring the significant potential ...